Skip to content

Evaluation of dermatological safety and adverse reaction of Tactivin Immunoplus (Immunomodulator) cream, Tactivin Anti Wrinkle cream and Tomicid (Antibacterial peptide) cream along with their Placebo with a 48 hours closed patch skin sensitization test on 24 healthy adult volunteers

Evaluation of dermatological safety and adverse reaction of Tactivin Immunoplus (Immunomodulator) cream, Tactivin Anti Wrinkle cream and Tomicid (Antibacterial peptide) cream along with their Placebo with a 48 hours closed patch skin sensitization test on 24 healthy adult volunteers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/11/002112
Enrollment
24
Registered
2011-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Tomicid Cream: The product is applied on upper back of healthy volunteers using Finn Chamber in the form of patch Intervention2: Tactivin Anti wrinkle Cream: The product is applied on u

Sponsors

Remedia Therapeutics Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy male and female adult volunteers Subjects willing to give a written informed consent. Subjects age group 18 - 55 years Subjects willing to maintain the patch test in position for 48 hours Subject has not participated in a similar investigation in the past two weeks. Subjects willing to come for regular follow up. Subjects ready to follow instructions during the study period.

Exclusion criteria

Exclusion criteria: The investigator can decide to withdraw a subject from the trial at any moment because One of the criteria of non inclusion occurred during the period of observation. Indication of intolerance to the studied product requiring that the investigation should be stopped.

Design outcomes

Primary

MeasureTime frame
dermatological safety and adverse reaction of tactivin immunoplus cream, tactivin anti wrinkle cream and tomicid creamTimepoint: 0hrs 48hrs 96hrs 168hrs

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable

Countries

India

Contacts

Public ContactDr Mukta Sachdev

MS Clinical Research Pvt Ltd

mscrploffice@gmail.com08041725416

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026